Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kestra Medical Technologies (KMTS) Non-Current Assets (2024 - 2026)

Kestra Medical Technologies (KMTS) has disclosed Non-Current Assets for 3 consecutive years, with $65.3 million as the latest value for Q1 2026.

  • Quarterly Non-Current Assets rose 71.43% to $65.3 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $202.6 million through Jan 2026, changed N/A year-over-year, with the annual reading at $40.4 million for FY2025, 30.2% up from the prior year.
  • Non-Current Assets for Q1 2026 was $65.3 million at Kestra Medical Technologies, up from $51.3 million in the prior quarter.
  • The five-year high for Non-Current Assets was $65.3 million in Q1 2026, with the low at $31.0 million in Q2 2024.
  • Average Non-Current Assets over 3 years is $45.3 million, with a median of $43.0 million recorded in 2025.
  • The sharpest move saw Non-Current Assets skyrocketed 30.2% in 2025, then soared 71.43% in 2026.
  • Over 3 years, Non-Current Assets stood at $31.0 million in 2024, then soared by 65.22% to $51.3 million in 2025, then increased by 27.28% to $65.3 million in 2026.
  • According to Business Quant data, Non-Current Assets over the past three periods came in at $65.3 million, $51.3 million, and $45.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.